Caraceni, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 2.180
AS - Asia 153
EU - Europa 145
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.480
Nazione #
US - Stati Uniti d'America 2.179
CN - Cina 103
IT - Italia 61
SE - Svezia 37
VN - Vietnam 37
FI - Finlandia 19
IN - India 9
DE - Germania 8
DK - Danimarca 7
GB - Regno Unito 6
FR - Francia 3
UA - Ucraina 3
PH - Filippine 2
CA - Canada 1
EG - Egitto 1
EU - Europa 1
NL - Olanda 1
SG - Singapore 1
TR - Turchia 1
Totale 2.480
Città #
Fairfield 453
Woodbridge 257
Chandler 202
Ashburn 191
Houston 178
Cambridge 164
Seattle 160
Ann Arbor 114
Wilmington 110
San Diego 48
Dong Ket 37
Beijing 31
Medford 27
Princeton 27
Padova 23
Des Moines 20
Boardman 19
Roxbury 18
Nanjing 14
Helsinki 13
Falls Church 8
Changsha 7
Guangzhou 6
Hebei 6
New York 6
Salerno 6
Shenyang 6
Rome 5
Tappahannock 5
Hefei 4
Lyngby 4
Tianjin 4
Zhengzhou 4
Aarhus 3
Jinan 3
Kharkiv 3
Nanchang 3
Bologna 2
Dearborn 2
Dongguan 2
Kunming 2
London 2
Makati City 2
Ningbo 2
Pavia 2
Saint-Fons 2
Washington 2
Absecon 1
Amsterdam 1
Augusta 1
Bari 1
Bonndorf 1
Borås 1
Cairo 1
Esslingen am Neckar 1
Fabriano 1
Geislingen an der Steige 1
Haikou 1
Hounslow 1
Kilburn 1
Macerata 1
Milan 1
North York 1
Piacenza 1
Pune 1
Rockville 1
Shanghai 1
Stockholm 1
Taizhou 1
Venezia 1
Verona 1
Wandsworth 1
Yenibosna 1
Totale 2.235
Nome #
Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial 150
Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections 142
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 140
Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis 125
Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide 116
Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure 110
Strategies to Restore Adenosine Triphosphate (ATP) Level After More than 20 Hours of Cold Ischemia Time in Human Marginal Kidney Grafts 105
The PREDICT study uncovers three clinical courses in acutely decompensated cirrhosis with distinct pathophysiology 102
Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe 100
The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure 98
AISF-SIMTI Position Paper: The appropriate use of albumin in patients with liver cirrhosis 97
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study 94
The Italian compassionate use of sofosbuvir in HCV patients waitlisted for liver transplantation: A national real-life experience 93
Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure 90
Specific issues concerning the management of patients on the waiting list and after liver transplantation 88
Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF 88
AISF-SIMTI position paper: The appropriate use of albumin in patients with liver cirrhosis 86
A Prospective Multicentre Study of the Epidemiology and Outcomes of Bloodstream Infection in Cirrhotic Patients 85
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 83
Successful Treatment of CCL4-Induced Acute Liver Failure With Portal Vein Arterialization in the Rat 82
Protective Effect of Portal Vein Arterialization in Acute Liver Failure Induced by Hepatectomy in Normal and Fatty Liver Rat 80
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 75
Portal Vein Arterialization for the Treatment of Post Resection Acute Liver Failure in the Rat 69
Risk factors for candidemia in hospitalized patients with liver cirrhosis: a multicenter case-control-control study 64
Technical Aspects of Portal Vein Arterialization for Acute Liver Failure: From Rat Lab to Man 61
Development and Validation of a Scoring System That Includes Corrected QT Interval For Risk Analysis of Patients With Cirrhosis and Gastrointestinal Bleeding 61
ENDPOINTS AND DESIGN OF CLINICAL TRIALS IN PATIENTS WITH DECOMPENSATED CIRRHOSIS: POSITION PAPER OF THE LIVERHOPE CONSORTIUM 34
Totale 2.518
Categoria #
all - tutte 8.095
article - articoli 8.095
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.190


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019231 0 0 0 0 0 0 0 0 0 45 96 90
2019/2020576 59 31 12 50 65 36 67 71 70 54 53 8
2020/2021599 26 73 23 26 18 32 20 71 52 90 77 91
2021/2022457 19 96 39 16 38 25 37 34 18 16 33 86
2022/2023339 73 41 4 51 49 39 1 17 39 1 18 6
2023/2024129 5 26 21 18 4 25 18 7 0 5 0 0
Totale 2.518